PlainPharmaWatch

CMS Open Payments · Tool

Edwards Lifesciences Corporation vs Abbott Laboratories

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Edwards Lifesciences Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 353, versus 23 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Edwards Lifesciences Corporation
HHI 353 · top recipient 0.2%
Ranked #1,417 of 1,838 companies by HHI
Abbott Laboratories
HHI 23 · top recipient 0.0%
Ranked #1,808 of 1,838 companies by HHI

Payment Overview

Total Payments
$93.0M
% of Industry
0.7%
Transactions
75,191
Avg per Transaction
$1.2K
Recipients
70,149
Avg per Recipient
$1.3K
Payment Types
12
Top Payment Type
Acquisitions
Total Payments
$91.7M
% of Industry
0.7%
Transactions
302,960
Avg per Transaction
$302.79
Recipients
292,558
Avg per Recipient
$313.56
Payment Types
11
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Edwards Lifesciences Corporation vs Abbott Laboratories - total reported payments in CMS Open Payments PY2024

Edwards Lifesciences Corpor…$93.0MAbbott Laboratories$91.7M

Payment Types Breakdown

Edwards Lifesciences Corporation

Acquisitions $8.0M

8.6%

Consulting Fee $7.8M

8.4%

Food and Beverage $3.1M

3.3%

Travel and Lodging $2.8M

3.0%

Royalty or License $1.6M

1.7%

Grant $1.4M

1.5%

Abbott Laboratories

Consulting Fee $10.3M

11.3%

Food and Beverage $10.2M

11.2%

Travel and Lodging $6.7M

7.3%

Compensation for Services Other Than Consulting $4.8M

5.2%

Grant $2.7M

2.9%

Education $1.1M

1.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Edwards Lifesciences Corporation

  1. 1

    ANTHONY NUNEZ

    $4,670,831.35 · 3 txns

  2. 2

    Cleveland Clinic Hospital

    $1,560,432.00 · 6 txns

  3. 3

    NICOLAS CHRONOS

    $889,686.38 · 5 txns

  4. 4

    Steward St. Elizabeths Medical Ctr

    $635,203.90 · 1 txns

  5. 5

    CHARANJIT RIHAL

    $473,082.11 · 2 txns

Abbott Laboratories

  1. 1

    Washington Hospital Center

    $1,259,500.00 · 22 txns

  2. 2

    CLAUDIO FELER

    $644,233.92 · 4 txns

  3. 3

    ROBERT J ALPERN

    $395,334.10 · 15 txns

  4. 4

    Montefiore Medical Center

    $342,239.83 · 18 txns

  5. 5

    St. Francis Hospital

    $266,600.00 · 6 txns

Summary Comparison

Metric Edwards Lifesciences Corporation Abbott Laboratories
Total Payments $93.0M $91.7M
% of Industry Total 0.7% 0.7%
Transaction Count 75,191 302,960
Avg per Transaction $1.2K $302.79
Recipient Count 70,149 292,558
Avg per Recipient $1.3K $313.56
Payment Type Count 12 11
Top Payment Type Acquisitions Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.